title: Complete remissions in non small cell lung cancer.
abstract: We studied 241 patients with non small cell bronchogenic cancer who were treated with cisplatin and etoposide or cisplatin, etoposide and vindesine. There were 11 (4.5%) complete responders in these series most of whom had a prolonged survival.
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002283:Carcinoma, Bronchogenic / Q000150:complications / Q000188:drug therapy* / Q000401:mortality; D002945:Cisplatin / Q000627:therapeutic use; D004334:Drug Administration Schedule; D005047:Etoposide / Q000627:therapeutic use; D006801:Humans; D008173:Lung Diseases, Obstructive / Q000150:complications; D008175:Lung Neoplasms / Q000150:complications / Q000188:drug therapy* / Q000401:mortality; D012189:Retrospective Studies; D012907:Smoking; D014751:Vindesine / Q000627:therapeutic use
chemical_list: D005047:Etoposide; D002945:Cisplatin; D014751:Vindesine